Research and Markets: Gene Therapy: Current Status and Prospects
Research and Markets (http://www.researchandmarkets.com/reports/c18775) has announced the addition of Gene Therapy: Current Status and Prospects to their offering. Dublin (PRWEB) June 10, 2005 — Research and Markets (http://www.researchandmarkets.com/reports/c18775) has announced the addition of Gene Therapy: Current Status and Prospects to their offering. Gene therapy (GT) is an exciting therapeutic approach in which diseases are treated by replacing or correcting defective genes with normal genes. Gene correction is carried out by delivering correct gene either as naked DNA or in a viral vector. Multiple vectors, retroviruses, and other gene delivery systems have been discovered, developed, and tested in pre-clinical research and in clinical trials. Overall, gene therapy has made tremendous progress in preclinical research and development, as well as in clinical studies for disease therapeutics. Since its inception, the key issue in gene therapy is the efficient delivery of the correct gene(s) to the diseased tissue. This report provides a detailed breakdown of the applications and markets for gene therapy as well as an analysis of future growth trends. The report details the latest developments of pre-clinical and clinical status in gene therapy areas. Delivery mechanisms in gene therapy such as viral and non-viral delivery systems are described in detail. The FDA regulation of gene therapy is overviewed as well. The report contains company profiles as well as expert opinions from those active in this area. For more information visit http://www.researchandmarkets.com/reports/c18775 Laura Wood Senior Manager Research and Markets e-mail protected from spam bots Fax: +353 1 4100 980
Discussion Area - Leave a Comment